CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in MRNA — Moderna, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in MRNA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$240,505,284
+$104,215,539 QoQ
Shares Held
4,734,356
+2.4% QoQ
Ownership
1.19%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.99702177022598.ToString("F0")%
Shared 0.ToString("F0")%
None 0.0029782297740178387.ToString("F0")%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,184,692,793 across 287 Biotechnology names. MRNA ranks #3 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
This page
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in MRNA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $240,505,284 | 4,734,356 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $136,289,745 | 4,621,558 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $111,390,118 | 4,312,432 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $83,876,828 | 3,040,117 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $74,556,672 | 2,629,865 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $97,471,960 | 2,344,203 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $142,533,486 | 2,132,777 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $243,401,281 | 2,049,695 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $209,666,283 | 1,967,589 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $186,110,630 | 1,871,399 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $186,028,491 | 1,801,031 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $212,889,870 | 1,752,180 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $275,262,509 | 1,792,307 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $315,855,124 | 1,758,463 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $206,894,811 | 1,749,639 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $233,640,031 | 1,635,562 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $279,670,483 | 1,623,537 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $399,633,974 | 1,573,486 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $591,843,865 | 1,537,816 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $189,809,089 | 807,767 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $102,291,068 | 781,146 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $76,779,495 | 734,943 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $50,693,790 | 716,520 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $93,490,723 | 1,456,015 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $30,485,356 | 1,017,875 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||